.Complying with a poor revealing for Lykos Therapies' MDMA applicant for trauma at a latest FDA cons...
.AN2 Therapeutics is reassessing its business in feedback to uninspired midphase data, swearing to g...
.Merck & Co. is paying out $700 million upfront to test Amgen in a blood stream cancer market. Th...
.Along With Gilead Sciences almost an FDA selection for its own liver ailment drug seladelpar, the b...
.Chief executive officer David Ricks may find the providers putting together outdoors tents at basec...
.Cushion Liquidators has switched Entero Rehabs white as a slab. The creditor bought Entero to settl...
.Exelixis is losing hope on its own tissue aspect (TF)- targeting antibody-drug conjugate after wrap...
.3 full weeks after Roche's Genentech unit ignored an SHP2 inhibitor pact, Relay Therapeutics has va...
.Stoke Therapeutics' Dravet syndrome medication has been actually without a predisposed grip, cleari...
.Tough Biotech Partner Publisher Gabrielle Masson presented the 2024 course of Brutal 15 champions o...